Testing effectiveness (Phase 2)Study completedNCT00515073What this trial is testingPapillary Serous Carcinoma of the EndometriumWho this might be right forEndometrial Cancer M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Not applicableStudy completedNCT01764789What this trial is testingStress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerWho this might be right forAnxiety DisorderDepressionFatigue+17 more Ohio State University Comprehensive Cancer Center 39
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Large-scale testing (Phase 3)Ended earlyNCT04159155What this trial is testingVarious Treatments in Serous or p53 Abnormal Endometrial CancerWho this might be right forEndometrial CarcinomaP53 MutationSerous Carcinoma University Health Network, Toronto 11
Testing effectiveness (Phase 2)Ended earlyNCT05001282What this trial is testingEvaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more Elucida Oncology 79
Testing effectiveness (Phase 2)Ended earlyNCT02059265What this trial is testingDasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+3 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00888173What this trial is testingBrivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+6 more Gynecologic Oncology Group 45
Early research (Phase 1)UnknownNCT05498597What this trial is testingAMT-151 in Patients With Selected Advanced Solid TumoursWho this might be right forAdvanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more Multitude Therapeutics Inc. 30
Testing effectiveness (Phase 2)Study completedNCT04814108What this trial is testingAzenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous CarcinomaWho this might be right forUterine Serous Carcinoma K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 92
Early research (Phase 1)Active Not RecruitingNCT04092270What this trial is testingA Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian CancerWho this might be right forEndometrial High Grade Endometrioid AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+26 more National Cancer Institute (NCI) 54
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Not applicableEnded earlyNCT03466034What this trial is testingThe Role of Hypoxia as a Selective Pressure for TP53 MutationsWho this might be right forEndometrial Cancer Institute of Cancer Research, United Kingdom 5
Early research (Phase 1)Ended earlyNCT04665921What this trial is testingSGN-STNV in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungHER2 Negative Breast NeoplasmsOvarian Neoplasms+9 more Seagen Inc. 111
Not applicableStudy completedNCT04458597What this trial is testingStereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.Who this might be right forEndometrioid AdenocarcinomaSerous CarcinomaClear Cell Carcinoma+2 more London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 23
Testing effectiveness (Phase 2)Looking for participantsNCT04716686What this trial is testingNiraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous CarcinomaWho this might be right forEndometrial CarcinomaSerous Carcinoma Shandong University 83
Testing effectiveness (Phase 2)Study completedNCT01642082What this trial is testingDalantercept in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+6 more Gynecologic Oncology Group 28
Testing effectiveness (Phase 2)UnknownNCT00492778What this trial is testingRadiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial CancerWho this might be right forEndometrial Endometrioid Adenocarcinoma, Variant With Squamous DifferentiationEndometrial Mucinous AdenocarcinomaEndometrial Squamous Cell Carcinoma+5 more GOG Foundation 165
Early research (Phase 1)Study completedNCT02020707What this trial is testingNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersWho this might be right forCervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more Mayo Clinic 43
Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center